SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001171843-15-000752
Filing Date
2015-02-11
Accepted
2015-02-11 17:01:22
Documents
18
Period of Report
2015-02-11
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K f8k_021115.htm 8-K 35897
2 EXHIBIT 99.1 exh_991.htm EX-99.1 16765
3 exh991_01.jpg GRAPHIC 87554
4 exh991_02.jpg GRAPHIC 215598
5 exh991_03.jpg GRAPHIC 139879
6 exh991_04.jpg GRAPHIC 134981
7 exh991_05.jpg GRAPHIC 169067
8 exh991_06.jpg GRAPHIC 142779
9 exh991_07.jpg GRAPHIC 131198
10 exh991_08.jpg GRAPHIC 153904
11 exh991_09.jpg GRAPHIC 154877
12 exh991_10.jpg GRAPHIC 154465
13 exh991_11.jpg GRAPHIC 182927
14 exh991_12.jpg GRAPHIC 190292
15 exh991_13.jpg GRAPHIC 143611
16 exh991_14.jpg GRAPHIC 124891
17 exh991_15.jpg GRAPHIC 130766
18 exh991_16.jpg GRAPHIC 87554
  Complete submission text file 0001171843-15-000752.txt   3285734
Mailing Address 100-8900 GLENLYON PARKWAY BURNABY A1 V5J 5J8
Business Address 100-8900 GLENLYON PARKWAY BURNABY A1 V5J 5J8 604-419-3200
TEKMIRA PHARMACEUTICALS Corp (Filer) CIK: 0001447028 (see all company filings)

IRS No.: 980597776 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34949 | Film No.: 15600325
SIC: 2834 Pharmaceutical Preparations